MANGANO, KATIA DOMENICA
 Distribuzione geografica
Continente #
NA - Nord America 4.349
EU - Europa 2.223
AS - Asia 1.508
SA - Sud America 394
AF - Africa 376
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.861
Nazione #
US - Stati Uniti d'America 4.188
IT - Italia 879
SG - Singapore 784
CN - Cina 537
IE - Irlanda 487
BR - Brasile 367
UA - Ucraina 339
CI - Costa d'Avorio 238
DE - Germania 160
CA - Canada 142
RU - Federazione Russa 134
SN - Senegal 100
SE - Svezia 54
GB - Regno Unito 34
KR - Corea 32
IN - India 30
FI - Finlandia 24
VN - Vietnam 21
FR - Francia 19
IR - Iran 18
BE - Belgio 16
PL - Polonia 15
BD - Bangladesh 13
UZ - Uzbekistan 13
CH - Svizzera 12
MX - Messico 12
AT - Austria 11
NG - Nigeria 10
TR - Turchia 9
AR - Argentina 8
GR - Grecia 8
IQ - Iraq 8
NL - Olanda 8
EC - Ecuador 7
MA - Marocco 7
PK - Pakistan 7
AU - Australia 6
GE - Georgia 6
HK - Hong Kong 6
MK - Macedonia 6
ZA - Sudafrica 6
TN - Tunisia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
JP - Giappone 4
LB - Libano 4
CZ - Repubblica Ceca 3
ES - Italia 3
ET - Etiopia 3
KE - Kenya 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
IL - Israele 2
LT - Lituania 2
NP - Nepal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LI - Liechtenstein 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.861
Città #
Santa Clara 797
Dublin 487
Singapore 475
Chandler 466
Jacksonville 410
Chicago 273
Catania 239
Abidjan 238
Houston 222
Boardman 215
Cambridge 130
Lawrence 130
Andover 127
Ashburn 121
Nanjing 115
Civitanova Marche 108
Toronto 103
Dakar 100
Hefei 76
Des Moines 73
San Mateo 60
Wilmington 52
Grafing 47
Nanchang 45
Saint Petersburg 45
Palermo 36
Hebei 33
Seoul 32
Bremen 29
Beijing 27
Ottawa 27
Jiaxing 24
Tianjin 24
Munich 23
Sant'Antonio Abate 23
Changsha 21
Columbus 21
São Paulo 21
Los Angeles 20
Rome 20
The Dalles 20
Falls Church 19
Shenyang 18
Vercelli 18
Dong Ket 17
Brussels 16
Chiaramonte Gulfi 16
Maletto 15
Nizza di Sicilia 15
Rio de Janeiro 15
Washington 15
Council Bluffs 14
Moscow 14
Augusta 11
Messina 11
Abuja 10
Ardabil 10
Brooklyn 10
Lappeenranta 10
Leawood 10
Turku 10
Acireale 9
Ragusa 9
San Francisco 9
Belo Horizonte 8
Boston 8
Dearborn 8
Hangzhou 8
Jinan 8
Licata 8
Mascalucia 8
Milan 8
Mumbai 8
Campinas 7
Padova 7
Pozzallo 7
Vienna 7
London 6
Monmouth Junction 6
Mountain View 6
Naples 6
New York 6
Paris 6
Skopje 6
Tbilisi 6
Aci Catena 5
Amsterdam 5
Atlanta 5
Baghdad 5
Brasília 5
Campobasso 5
Dhaka 5
Guangzhou 5
Hong Kong 5
Juiz de Fora 5
Liberty Lake 5
Misterbianco 5
Recife 5
Redmond 5
Reggio Calabria 5
Totale 6.079
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 304
Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. 259
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 131
Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens 113
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 106
Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease 94
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 90
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 90
Anti-inflammatory and immune regulatory properties of 5-androsten-3 beta,17 beta-diol (HE2100), and synthetic analogue HE3204 implications for treatment of autoimmune diseases 89
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 88
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 85
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 85
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 82
Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study 80
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 80
Emerging therapeutic targets for the treatment of hepatic fibrosis 78
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 78
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 78
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 77
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 77
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 76
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 76
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 76
Detection of BRAF gene mutation in primary choroidal melanoma tissue 75
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 75
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 74
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 74
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 73
Anti-melanoma potential of nitric oxide modified form of HIV inhibitor-saquinavir; cell specific mode of drug action 73
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 72
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 72
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 72
Immunomodulatory properties of cefaclor: In vivo effect on cytokines release and lymphoprolipherative response on rat 71
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 71
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 71
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 70
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 70
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 70
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 69
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 69
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 69
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 68
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 67
The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy 67
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma 67
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 66
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 64
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 64
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo 64
No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells/MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN 64
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus 64
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 63
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 63
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells 63
The dichotomic role of macrophage migration inhibitory factor in neurodegeneration 63
Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma 63
The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis 62
Expression of DNA methylation genes in secondary progressive multiple sclerosis 62
Bone Marrow-Derived Mesenchymal Stem Cells To Augment Liver Regeneration in a Preclinical Model of Acute Liver Failure in Rats 62
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 62
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis 61
The immunobiology of apotransferrin in type 1 diabetes 60
Therapeutic effects of single administration of Cyclophosphamide in rat experimental autoimmune neuritis, a pre-clinical model of autoimmune peripheral neuropathies 60
Protection against murine endotoxemia by treatment with Ruta Chalepensis L., a plant with anti-inflammatory properties 60
Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14 60
Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor properties 59
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 59
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 58
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 58
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 58
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 58
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 58
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus 57
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 57
Modulation of tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis 57
Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL 56
Glycopeptide- and carbohydrate-based synthetic vaccines for cancer immunotherapy 56
Novel components of the human metabolome: The identification, characterization and anti-inflammatory activity of two 5-androstene tetrols 56
Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents 55
Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents 55
Effects of combined admistration of imatinib and sorafenib in a murine model of liver fibrosis 55
Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? 55
Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures 54
In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models 54
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study 53
Therapeutic potential of carbon monoxide in multiple sclerosis 53
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 53
Increased serum levels of interleukin-18 in patients with multiple sclerosis 53
The role of macrophage migration inhibitory factor in Alzheimer′s disease: Conventionally pathogenetic or unconventionally protective? 53
Cytotoxic and Immune-Sensitizing Properties of Nitric Oxide-Modified Saquinavir in iNOS-Positive Human Melanoma Cells 51
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 51
HE3286: A Novel Synthetic Steroid as an Oral Treatment for Autoimmune Disease 51
Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats 51
Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir. 50
Transcriptomic analysis reveals involvement of the macrophage migration inhibitory factor gene network in duchenne muscular dystrophy 50
Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND 49
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 49
Ischemia/reperfusion- models and modulations 48
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 48
MAPK and AKT pathways are activated in melanoma by BRAF, NRAS and PIK3CA mutations 48
Totale 7.087
Categoria #
all - tutte 37.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021739 16 48 85 17 194 15 82 1 89 1 154 37
2021/2022986 101 128 10 21 157 26 141 33 77 9 27 256
2022/20231.639 145 81 27 146 135 254 14 301 397 32 56 51
2023/2024891 57 110 46 64 31 288 8 79 5 30 96 77
2024/20253.314 41 479 195 168 777 320 185 103 234 292 292 228
2025/2026111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 9.089